Nuveen Asset Management, LLC Axonics, Inc. Transaction History

Nuveen Asset Management, LLC

$329 Billion
Q1 2024

A detailed history of Nuveen Asset Management, LLC transactions in Axonics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 455,944 shares of AXNX stock, worth $30.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

455,944

Previous 594,161 23.26%

Holding current value

$30.8 Million

Previous $37 Million 14.95%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$56.67 - $69.36 $7.83 Million - $9.59 Million	-138,217 Reduced 23.26%	455,944 $31.4 Million
Q4 2023 Feb 14, 2024	SELL	$49.38 - $63.75 $30,714 - $39,652	-622 Reduced 0.1%	594,161 $37 Million
Q3 2023 Nov 14, 2023	SELL	$48.64 - $62.51 $1.17 Million - $1.5 Million	-24,015 Reduced 3.88%	594,783 $33.4 Million
Q2 2023 Aug 14, 2023	BUY	$47.99 - $60.21 $1.85 Million - $2.32 Million	38,469 Added 6.63%	618,798 $31.2 Million
Q1 2023 May 15, 2023	SELL	$52.6 - $67.34 $7.8 Million - $9.99 Million	-148,290 Reduced 20.35%	580,329 $31.7 Million

Q4 2022 Feb 14, 2023	SELL	$59.56 - $76.6 $48,005 - $61,739	-806 Reduced 0.11%	728,619 $45.6 Million
Q3 2022 Nov 14, 2022	BUY	$57.96 - $78.12 $16 Million - $21.6 Million	276,221 Added 60.95%	729,425 $51.4 Million
Q2 2022 Aug 15, 2022	BUY	$39.5 - $64.42 $688,050 - $1.12 Million	17,419 Added 4.0%	453,204 $25.7 Million
Q1 2022 May 16, 2022	BUY	$43.74 - $62.76 $2.12 Million - $3.04 Million	48,488 Added 12.52%	435,785 $24.3 Million
Q4 2021 Feb 14, 2022	BUY	$50.01 - $73.35 $271,604 - $398,363	5,431 Added 1.42%	387,297 $21.7 Million
Q3 2021 Nov 12, 2021	BUY	$59.21 - $78.66 $1.44 Million - $1.92 Million	24,352 Added 6.81%	381,866 $24.9 Million
Q2 2021 Aug 16, 2021	BUY	$51.39 - $66.9 $12.7 Million - $16.6 Million	247,732 Added 225.66%	357,514 $22.7 Million
Q1 2021 May 17, 2021	SELL	$49.14 - $59.89 $165,896 - $202,188	-3,376 Reduced 2.98%	109,782 $6.58 Million
Q4 2020 Feb 16, 2021	SELL	$42.19 - $51.5 $99,821 - $121,849	-2,366 Reduced 2.05%	113,158 $5.65 Million
Q3 2020 Nov 16, 2020	SELL	$35.33 - $51.04 $1.06 Million - $1.54 Million	-30,079 Reduced 20.66%	115,524 $5.9 Million
Q2 2020 Aug 14, 2020	BUY	$22.91 - $39.83 $343,168 - $596,613	14,979 Added 11.47%	145,603 $5.11 Million
Q1 2020 May 14, 2020	BUY	$16.44 - $37.73 $127,344 - $292,256	7,746 Added 6.3%	130,624 $3.32 Million
Q4 2019 Feb 14, 2020	BUY	$19.57 - $28.96 $1.16 Million - $1.71 Million	59,140 Added 92.79%	122,878 $3.41 Million
Q3 2019 Nov 14, 2019	BUY	$26.92 - $42.41 $54,001 - $85,074	2,006 Added 3.25%	63,738 $1.72 Million
Q2 2019 Aug 15, 2019	BUY	$18.54 - $40.97 $1.14 Million - $2.53 Million	61,732 New	61,732 $2.53 Million

Others Institutions Holding AXNX

# of Institutions

241

Shares Held

41.8M

Call Options Held

213K

Put Options Held

362K

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.31B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Axonics, Inc. Transaction History